Medical Experts Address Hair Loss Concerns Linked to GLP-1 Drugs

Dermatologists and medical experts are increasingly advising patients on managing hair loss, a reported side effect associated with the use of GLP-1 weight-loss medications like Ozempic and Wegovy.

A study released on August 21, 2026, explores the correlation between rapid weight loss and telogen effluvium, emphasizing the need for nutritional support during treatment.

Patients are encouraged to consult with their healthcare providers to discuss scalp health and potential supplement regimens to mitigate thinning while maintaining their weight-loss progress.